Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesHigh-Dose Esomeprazole for Treatment of Symptomatic Refractory Gastroesophageal Reflux Disease - A Prospective pH-Metry/Impedance-Controlled Study
Digestion, 07/28/09
Meining A et al. – In patients with abnormal pH/MII and persistent symptoms under 40 mg esomeprazole, the authors observed a significant reduction in liquid/mixed reflux events after increasing proton pump inhibitor dose up to 80 mg esomeprazole.
Related Articles
Gastroesophageal Reflux Might Cause Esophagitis Through a Cytokine-Mediated Mechanism Rather Than Caustic Acid Injury
Gastroenterology, 10/28/09
Relevance Score: 81%
Trends in Gastroesophageal Reflux Disease as Measured by the National Ambulatory Medical Care Survey
Digestive Diseases and Sciences, 10/27/09
Relevance Score: 81%
Evaluating outcomes of endoscopic full-thickness plication for gastroesophageal reflux disease with impedance monitoring
Surgical Endoscopy, 11/16/09
Relevance Score: 80%
XenoPort Announces Initiation of a Phase 2b Clinical Trial of Arbaclofen Placarbil in Patients with Gastroesophageal Reflux Disease
XenoPort, 10/20/09
Relevance Score: 80%
Assessment of Airway Inflammation by Exhaled Breath Condensate and Impedance Due to Gastroesophageal Reflux Disease (GERD)
Inflammation & Allergy - Drug Targets, 10/12/09
Relevance Score: 80%
Today in Dosing...keeping you current
Receive free subspecialty "5-minute updates" via email
Safety and pharmacokinetics of subcutaneous ceftriaxone administered with or without recombinant human hyaluronidase (rHuPH20) versus intravenous ceftriaxone administration in adult volunteers
Current Medical Research and Opinion, 12/08/09
Glatiramer acetate has no impact on disease progression in ALS at 40 mg/day: A double- blind, randomized, multicentre, placebo-controlled trial
Amyotrophic Lateral Sclerosis, 12/07/09
Potential interactions between cilostazol and probucol: A two-part, single-dose, open-label study in healthy Korean male volunteers
Clinical Therapeutics, 12/07/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Monocarboxylate Transporter (MCT)-mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells
Drug Metabolism and Disposition, 12/08/09
Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
American Journal of Health-System Pharmacy, 12/08/09
Resveratrol (trans-3, 5, 4'-trihydroxystilbene) induces SIRT1 and down-regulates NF-kB activation to abrogate DSS-induced colitis
Journal of Pharmacology and Experimental Therapeutics, 12/07/09
Sponsor
Article Search
Sponsor